Oceanusbio

Oceanusbio is a Tokyo-based pharmaceutical company transforming clinical drug development through an unconventional, agile strategy designed to address the 'drug loss' and 'drug lag' challenges facing Japan and Asia. The company sources innovative medicines approved in the US and EU and facilitates their delivery to Japanese and Asian patients by executing rapid, cost-effective clinical trials and regulatory approvals with a lean team. Leveraging cutting-edge technology and advanced data analytics across R&D, regulatory, medical, and commercial functions, Oceanusbio aims to bridge the gap left as multinational pharma companies reduce simultaneous global clinical trial programs. Its competitive advantage lies in its ability to outpace traditional development models and bring breakthrough therapies to underserved Asian markets faster and more economically.